Relationship	O
between	O
leucine	B:C1425650
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	O
polymorphism	I:C0752046
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

Relationship	O
between	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	B:C0752046
polymorphism	I:C0752046
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

Relationship	O
between	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	O
polymorphism	I:C0752046
and	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

Relationship	O
between	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	O
polymorphism	I:C0752046
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	B:C0078988
populations	I:C0078988
.	O

Although	O
the	O
leucine	B:C1425650
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
(	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
)	O
R1628P	O
polymorphism	I:C0752046
has	O
been	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
in	O
Taiwan	O
,	O
China	O
,	O
and	O
Singapore	O
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	O
.	O

Although	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
(	O
leucine	B:C1425650
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
)	O
R1628P	O
polymorphism	I:C0752046
has	O
been	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
in	O
Taiwan	O
,	O
China	O
,	O
and	O
Singapore	O
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	O
.	O

Although	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
(	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
)	O
R1628P	B:C0752046
polymorphism	I:C0752046
has	O
been	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
in	O
Taiwan	O
,	O
China	O
,	O
and	O
Singapore	O
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	O
.	O

Although	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
(	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
)	O
R1628P	O
polymorphism	I:C0752046
has	O
been	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
in	O
Taiwan	O
,	O
China	O
,	O
and	O
Singapore	O
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	O
.	O

Although	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
(	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
)	O
R1628P	O
polymorphism	I:C0752046
has	O
been	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
)	O
in	O
Taiwan	O
,	O
China	O
,	O
and	O
Singapore	O
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	O
.	O

Although	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
(	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
)	O
R1628P	O
polymorphism	I:C0752046
has	O
been	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
in	O
Taiwan	B:C0039260
,	O
China	O
,	O
and	O
Singapore	O
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	O
.	O

Although	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
(	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
)	O
R1628P	O
polymorphism	I:C0752046
has	O
been	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
in	O
Taiwan	O
,	O
China	B:C0008115
,	O
and	O
Singapore	O
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	O
.	O

Although	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
(	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
)	O
R1628P	O
polymorphism	I:C0752046
has	O
been	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
(	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
)	O
in	O
Taiwan	O
,	O
China	O
,	O
and	O
Singapore	B:C0037173
,	O
there	O
are	O
conflicting	O
findings	O
regarding	O
this	O
relationship	O
.	O

Thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
meta-	B:C0920317
analysis	I:C0920317
was	O
to	O
evaluate	O
the	O
associations	O
between	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	O
polymorphism	I:C0752046
(	O
rs33949390	O
)	O
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

Thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
meta-	O
analysis	I:C0920317
was	O
to	O
evaluate	O
the	O
associations	O
between	O
the	O
leucine	B:C1425650
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	O
polymorphism	I:C0752046
(	O
rs33949390	O
)	O
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

Thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
meta-	O
analysis	I:C0920317
was	O
to	O
evaluate	O
the	O
associations	O
between	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	B:C0752046
polymorphism	I:C0752046
(	O
rs33949390	O
)	O
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

Thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
meta-	O
analysis	I:C0920317
was	O
to	O
evaluate	O
the	O
associations	O
between	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	O
polymorphism	I:C0752046
(	O
rs33949390	B:C0752046
)	O
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

Thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
meta-	O
analysis	I:C0920317
was	O
to	O
evaluate	O
the	O
associations	O
between	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	O
polymorphism	I:C0752046
(	O
rs33949390	O
)	O
and	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

Thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
meta-	O
analysis	I:C0920317
was	O
to	O
evaluate	O
the	O
associations	O
between	O
the	O
leucine	O
-	I:C1425650
rich	I:C1425650
repeat	I:C1425650
kinase	I:C1425650
2	I:C1425650
R1628P	O
polymorphism	I:C0752046
(	O
rs33949390	O
)	O
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	B:C0078988
populations	I:C0078988
.	O

A	O
search	O
for	O
eligible	O
studies	B:C2603343
was	O
performed	O
in	O
PubMed	O
,	O
Embase	O
,	O
SinoMed	O
,	O
and	O
the	O
China	O
Knowledge	I:C0242356
Resource	I:C0242356
Integrated	I:C0242356
Database	I:C0242356
,	O
and	O
pooled	O
odds	O
ratios	O
and	O
95	O
%	O
confidence	O
intervals	O
were	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
association	O
between	O
the	O
R1628P	O
polymorphism	I:C0752046
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

A	O
search	O
for	O
eligible	O
studies	O
was	O
performed	O
in	O
PubMed	B:C1138432
,	O
Embase	O
,	O
SinoMed	O
,	O
and	O
the	O
China	O
Knowledge	I:C0242356
Resource	I:C0242356
Integrated	I:C0242356
Database	I:C0242356
,	O
and	O
pooled	O
odds	O
ratios	O
and	O
95	O
%	O
confidence	O
intervals	O
were	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
association	O
between	O
the	O
R1628P	O
polymorphism	I:C0752046
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

A	O
search	O
for	O
eligible	O
studies	O
was	O
performed	O
in	O
PubMed	O
,	O
Embase	B:C0079198
,	O
SinoMed	O
,	O
and	O
the	O
China	O
Knowledge	I:C0242356
Resource	I:C0242356
Integrated	I:C0242356
Database	I:C0242356
,	O
and	O
pooled	O
odds	O
ratios	O
and	O
95	O
%	O
confidence	O
intervals	O
were	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
association	O
between	O
the	O
R1628P	O
polymorphism	I:C0752046
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

A	O
search	O
for	O
eligible	O
studies	O
was	O
performed	O
in	O
PubMed	O
,	O
Embase	O
,	O
SinoMed	B:C0079198
,	O
and	O
the	O
China	O
Knowledge	I:C0242356
Resource	I:C0242356
Integrated	I:C0242356
Database	I:C0242356
,	O
and	O
pooled	O
odds	O
ratios	O
and	O
95	O
%	O
confidence	O
intervals	O
were	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
association	O
between	O
the	O
R1628P	O
polymorphism	I:C0752046
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

A	O
search	O
for	O
eligible	O
studies	O
was	O
performed	O
in	O
PubMed	O
,	O
Embase	O
,	O
SinoMed	O
,	O
and	O
the	O
China	B:C0242356
Knowledge	I:C0242356
Resource	I:C0242356
Integrated	I:C0242356
Database	I:C0242356
,	O
and	O
pooled	O
odds	O
ratios	O
and	O
95	O
%	O
confidence	O
intervals	O
were	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
association	O
between	O
the	O
R1628P	O
polymorphism	I:C0752046
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

A	O
search	O
for	O
eligible	O
studies	O
was	O
performed	O
in	O
PubMed	O
,	O
Embase	O
,	O
SinoMed	O
,	O
and	O
the	O
China	O
Knowledge	I:C0242356
Resource	I:C0242356
Integrated	I:C0242356
Database	I:C0242356
,	O
and	O
pooled	O
odds	O
ratios	O
and	O
95	O
%	O
confidence	O
intervals	O
were	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
association	O
between	O
the	O
R1628P	B:C0752046
polymorphism	I:C0752046
and	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

A	O
search	O
for	O
eligible	O
studies	O
was	O
performed	O
in	O
PubMed	O
,	O
Embase	O
,	O
SinoMed	O
,	O
and	O
the	O
China	O
Knowledge	I:C0242356
Resource	I:C0242356
Integrated	I:C0242356
Database	I:C0242356
,	O
and	O
pooled	O
odds	O
ratios	O
and	O
95	O
%	O
confidence	O
intervals	O
were	O
used	O
to	O
evaluate	O
the	O
strength	O
of	O
the	O
association	O
between	O
the	O
R1628P	O
polymorphism	I:C0752046
and	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
.	O

This	O
meta	B:C0920317
-	I:C0920317
analysis	I:C0920317
assessed	O
19	O
studies	O
from	O
14	O
papers	O
that	O
involved	O
a	O
total	O
of	O
9,927	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
patients	O
and	O
8,602	O
controls	O
and	O
found	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

This	O
meta	O
-	I:C0920317
analysis	I:C0920317
assessed	O
19	O
studies	B:C2603343
from	O
14	O
papers	O
that	O
involved	O
a	O
total	O
of	O
9,927	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
patients	O
and	O
8,602	O
controls	O
and	O
found	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

This	O
meta	O
-	I:C0920317
analysis	I:C0920317
assessed	O
19	O
studies	O
from	O
14	O
papers	O
that	O
involved	O
a	O
total	O
of	O
9,927	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
patients	O
and	O
8,602	O
controls	O
and	O
found	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

This	O
meta	O
-	I:C0920317
analysis	I:C0920317
assessed	O
19	O
studies	O
from	O
14	O
papers	O
that	O
involved	O
a	O
total	O
of	O
9,927	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
patients	O
and	O
8,602	O
controls	O
and	O
found	O
that	O
the	O
R1628P	B:C0752046
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

This	O
meta	O
-	I:C0920317
analysis	I:C0920317
assessed	O
19	O
studies	O
from	O
14	O
papers	O
that	O
involved	O
a	O
total	O
of	O
9,927	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
patients	O
and	O
8,602	O
controls	O
and	O
found	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
in	O
Asian	O
populations	I:C0078988
.	O

This	O
meta	O
-	I:C0920317
analysis	I:C0920317
assessed	O
19	O
studies	O
from	O
14	O
papers	O
that	O
involved	O
a	O
total	O
of	O
9,927	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
patients	O
and	O
8,602	O
controls	O
and	O
found	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
the	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Asian	B:C0078988
populations	I:C0078988
.	O

Moreover	O
,	O
stratification	B:C1514983
analyses	I:C1514983
indicated	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
among	O
Chinese	O
as	O
well	O
as	O
non-Chinese	O
Asian	I:C0078988
populations	I:C0078988
and	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Chinese	O
patients	O
from	O
China	O
,	O
Taiwan	O
,	O
and	O
Singapore	O
.	O

Moreover	O
,	O
stratification	O
analyses	I:C1514983
indicated	O
that	O
the	O
R1628P	B:C0752046
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
among	O
Chinese	O
as	O
well	O
as	O
non-Chinese	O
Asian	I:C0078988
populations	I:C0078988
and	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Chinese	O
patients	O
from	O
China	O
,	O
Taiwan	O
,	O
and	O
Singapore	O
.	O

Moreover	O
,	O
stratification	O
analyses	I:C1514983
indicated	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
among	O
Chinese	O
as	O
well	O
as	O
non-Chinese	O
Asian	I:C0078988
populations	I:C0078988
and	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Chinese	O
patients	O
from	O
China	O
,	O
Taiwan	O
,	O
and	O
Singapore	O
.	O

Moreover	O
,	O
stratification	O
analyses	I:C1514983
indicated	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
among	O
Chinese	B:C0152035
as	O
well	O
as	O
non-Chinese	O
Asian	I:C0078988
populations	I:C0078988
and	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Chinese	O
patients	O
from	O
China	O
,	O
Taiwan	O
,	O
and	O
Singapore	O
.	O

Moreover	O
,	O
stratification	O
analyses	I:C1514983
indicated	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
among	O
Chinese	O
as	O
well	O
as	O
non-Chinese	B:C0078988
Asian	I:C0078988
populations	I:C0078988
and	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Chinese	O
patients	O
from	O
China	O
,	O
Taiwan	O
,	O
and	O
Singapore	O
.	O

Moreover	O
,	O
stratification	O
analyses	I:C1514983
indicated	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
among	O
Chinese	O
as	O
well	O
as	O
non-Chinese	O
Asian	I:C0078988
populations	I:C0078988
and	O
an	O
increased	O
risk	O
of	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
in	O
Chinese	O
patients	O
from	O
China	O
,	O
Taiwan	O
,	O
and	O
Singapore	O
.	O

Moreover	O
,	O
stratification	O
analyses	I:C1514983
indicated	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
among	O
Chinese	O
as	O
well	O
as	O
non-Chinese	O
Asian	I:C0078988
populations	I:C0078988
and	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Chinese	O
patients	O
from	O
China	B:C0008115
,	O
Taiwan	O
,	O
and	O
Singapore	O
.	O

Moreover	O
,	O
stratification	O
analyses	I:C1514983
indicated	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
among	O
Chinese	O
as	O
well	O
as	O
non-Chinese	O
Asian	I:C0078988
populations	I:C0078988
and	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Chinese	O
patients	O
from	O
China	O
,	O
Taiwan	B:C0039260
,	O
and	O
Singapore	O
.	O

Moreover	O
,	O
stratification	O
analyses	I:C1514983
indicated	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
was	O
significantly	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
among	O
Chinese	O
as	O
well	O
as	O
non-Chinese	O
Asian	I:C0078988
populations	I:C0078988
and	O
an	O
increased	O
risk	O
of	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
in	O
Chinese	O
patients	O
from	O
China	O
,	O
Taiwan	O
,	O
and	O
Singapore	B:C0037173
.	O

In	O
a	O
stratified	B:C1514983
analysis	I:C1514983
conducted	O
according	O
to	O
age	O
,	O
significant	O
associations	O
were	O
found	O
for	O
both	O
late	O
-	O
onset	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
and	O
early	O
-	O
onset	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

In	O
a	O
stratified	O
analysis	I:C1514983
conducted	O
according	O
to	O
age	O
,	O
significant	O
associations	O
were	O
found	O
for	O
both	O
late	O
-	O
onset	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
and	O
early	O
-	O
onset	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
.	O

In	O
a	O
stratified	O
analysis	I:C1514983
conducted	O
according	O
to	O
age	O
,	O
significant	O
associations	O
were	O
found	O
for	O
both	O
late	O
-	O
onset	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
and	O
early	O
-	O
onset	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
.	O

The	O
present	O
data	O
indicate	O
that	O
the	O
R1628P	B:C0752046
polymorphism	I:C0752046
of	O
the	O
LRRK2	O
gene	I:C1425650
contributes	O
to	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
susceptibility	O
in	O
Asian	O
,	O
especially	O
Chinese	O
,	O
populations	O
.	O

The	O
present	O
data	O
indicate	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
of	O
the	O
LRRK2	B:C1425650
gene	I:C1425650
contributes	O
to	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
susceptibility	O
in	O
Asian	O
,	O
especially	O
Chinese	O
,	O
populations	O
.	O

The	O
present	O
data	O
indicate	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
of	O
the	O
LRRK2	O
gene	I:C1425650
contributes	O
to	O
Parkinson	B:C0030567
's	I:C0030567
disease	I:C0030567
susceptibility	O
in	O
Asian	O
,	O
especially	O
Chinese	O
,	O
populations	O
.	O

The	O
present	O
data	O
indicate	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
of	O
the	O
LRRK2	O
gene	I:C1425650
contributes	O
to	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
susceptibility	B:C0012655
in	O
Asian	O
,	O
especially	O
Chinese	O
,	O
populations	O
.	O

The	O
present	O
data	O
indicate	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
of	O
the	O
LRRK2	O
gene	I:C1425650
contributes	O
to	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
susceptibility	O
in	O
Asian	B:C0078988
,	O
especially	O
Chinese	O
,	O
populations	O
.	O

The	O
present	O
data	O
indicate	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
of	O
the	O
LRRK2	O
gene	I:C1425650
contributes	O
to	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
susceptibility	O
in	O
Asian	O
,	O
especially	O
Chinese	B:C0152035
,	O
populations	O
.	O

The	O
present	O
data	O
indicate	O
that	O
the	O
R1628P	O
polymorphism	I:C0752046
of	O
the	O
LRRK2	O
gene	I:C1425650
contributes	O
to	O
Parkinson	O
's	I:C0030567
disease	I:C0030567
susceptibility	O
in	O
Asian	O
,	O
especially	O
Chinese	O
,	O
populations	B:C1257890
.	O

